VEITH 22: Findings From the BEST-CLI Trial | Dr Farber, Dr Rosenfield & Dr Menard

VEITHsymposium 22: Findings From the BEST-CLI Trial | Dr Farber, Dr Rosenfield & Dr MenardПодробнее

VEITHsymposium 22: Findings From the BEST-CLI Trial | Dr Farber, Dr Rosenfield & Dr Menard

VEITHsymposium 22: Paclitaxel Mortality SignalsПодробнее

VEITHsymposium 22: Paclitaxel Mortality Signals

How RADARs use CFAR to detect targetsПодробнее

How RADARs use CFAR to detect targets

In Focus: The BEST CLI Trial - An RCT of endo vs open surgery in CLTI with infrainginal diseaseПодробнее

In Focus: The BEST CLI Trial - An RCT of endo vs open surgery in CLTI with infrainginal disease

ESVS 2019: Best CLI Trial Update-Dr Alik Farber And Dr Stephen BlackПодробнее

ESVS 2019: Best CLI Trial Update-Dr Alik Farber And Dr Stephen Black

BEST CLI Trial - How Is This Trial Impacting My Practice?Подробнее

BEST CLI Trial - How Is This Trial Impacting My Practice?

VEITH 22: Findings From the BEST-CLI Trial | Dr Farber, Dr Rosenfield & Dr MenardПодробнее

VEITH 22: Findings From the BEST-CLI Trial | Dr Farber, Dr Rosenfield & Dr Menard

Main Outcomes Of The BEST CLI RCT-Major Highlight at the 49th Annual VEITHsymposium in New York CityПодробнее

Main Outcomes Of The BEST CLI RCT-Major Highlight at the 49th Annual VEITHsymposium in New York City

EHRA 22: EAST-AFNET 4 in Clinical Practice | Dr Paulus KirchhofПодробнее

EHRA 22: EAST-AFNET 4 in Clinical Practice | Dr Paulus Kirchhof

Forum Cure Project - Session 7: Case Study of the RV397 ProtocolПодробнее

Forum Cure Project - Session 7: Case Study of the RV397 Protocol

What Are the Results of the REVIVE-2 Trial?Подробнее

What Are the Results of the REVIVE-2 Trial?

Impact of global viral surveillance on diagnostic toolsПодробнее

Impact of global viral surveillance on diagnostic tools

HRS 22: Findings From a Sub-Analysis of EAST-AFNET 4 | Dr Andreas RilligПодробнее

HRS 22: Findings From a Sub-Analysis of EAST-AFNET 4 | Dr Andreas Rillig

BASIL Trials Investigators' Meeting, Birmingham 2018: 14b. BEST-CLI Trial (PART 2)Подробнее

BASIL Trials Investigators' Meeting, Birmingham 2018: 14b. BEST-CLI Trial (PART 2)

Dr. Keith D. Calligaro and Dr. Vikram S. KashyapПодробнее

Dr. Keith D. Calligaro and Dr. Vikram S. Kashyap